South America News

Found 1,443 articles

• Auris Medical Holding Ltd Provides Corporate Update

  5/23/2019

  Auris Medical Holding Ltd. provided a business update, including a review of recent clinical, regulatory and operational highlights and progress.

• Bioceres Crop Solutions Corp. Reports Third Quarter Financial Results and Announces Debt Restructuring Agreements

  5/23/2019

  Adjusted EBITDA for the nine-month period ended March 31, 2019 increased by 94%. Management expects to exceed guidance of $38 million for fiscal year ending June 30, 2019.

• Luxfer to Showcase Lightweight L7X® Medical Cylinders at Hospitalar 2019

  5/21/2019

  Luxfer Gas Cylinders, a business unit of Luxfer Holdings PLC (NYSE: LXFR) and the world’s largest manufacturer of high-pressure composite and aluminium cylinders, will showcase its lightweight L7X® medical cylinders at Hospitalar 2019 in Gaswide’s booth #170, Expo Center Norte, Sao Paolo. Gaswide is a Brazil distributor for Luxfer medical cylinders.

• Brazil’s Prestigious Santa Casa Hospital System Chooses Carestream for a Unified Diagnostic Workflow

  5/21/2019

  Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all seven of its hospitals in Porto Alegre, the capital and largest city of the Brazilian state of Rio Grande do Sul.

• Auris Medical Holding Ltd Regains Compliance with Nasdaq Minimum Bid Price Rule

  5/20/2019

  Auris Medical Holding Ltd. announced that it has received written notification from the Nasdaq Hearings Panel notifying the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market.

• Gelymar Doubles its Production Capacity

  5/20/2019

  Sustainable strategy drive demand and expansion for renewable carrageenan

• Auris Medical Announces Closing of Public Offering of Common Shares

  5/15/2019

  Auris Medical Holding Ltd. announced today the closing of its previously announced underwritten public offering

• Auris Medical Announces Closing of Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD

  5/15/2019

  Auris Medical Holding Ltd. today announced the successful closing of the purchase of two US patents related to the use of betahistine for the treatment of depression and attention-deficit / hyperactivity disorder (ADHD).

• Auris Medical Prices $8,000,000 Public Offering

  5/13/2019

  Auris Medical Holding Ltd. announced the pricing of an underwritten public offering of: (i) 330,000 common shares together with warrants to purchase 330,000 common shares, and (ii) 1,721,280 pre-funded warrants, with each pre-funded warrant exercisable for one common share, together with warrants to purchase 1,721,280 common shares.

• Triple-S Management Corporation Reports First Quarter 2019 Results

  5/9/2019

  Triple-S Management Corporation (NYSE:GTS), a leading managed care company in Puerto Rico, announced its first quarter 2019 results.

• Auris Medical Reaches Midpoint for Enrollment in AM-201 Phase 1b Proof-of-Concept Study in Antipsychotic-Induced Weight Gain

  5/7/2019

  Auris Medical Holding Ltd. announced that it has reached the midpoint for enrollment in its Phase 1b proof-of-concept trial of AM-201, the Company’s investigational drug for the prevention of antipsychotic-induced weight gain and somnolence.

• CINDE Announces: Costa Rica Creates First Microcontroller for Medical Applications Microcircuit Completely Designed and Developed in the Country

  5/7/2019

  The DCILab of the Electronic Engineering School at the Technological Institute of Costa Rica (TEC by its Spanish acronym), has created the first RISC, 32-bit microcontroller completely designed and developed in Costa Rica, for a microcircuit with medical applications.

• Hanni Ali Joins Leadership Team at MIT's SOLVE Global Challenge

  5/6/2019

  Hanni Ali will be representing Hamilton this week at the flagship meeting of SOLVE, a global initiative that facilitates technology-based solutions to pressing issues facing the world's communities.

• Auris Medical Announces Reverse Stock Split

  4/30/2019

  Auris Medical Holding Ltd. announced that its Board of Directors has approved a reverse stock split of its common shares at a ratio of 1-for-20.

• Beaches Resorts Becomes First Resort Company In The World To Attain Advanced Certified Autism Center Credential

  4/30/2019

  The Resorts for Everyone Take Commitment to Inclusivity to the Highest Level

• Genomma Lab Internacional Reports First Quarter 2019 Results

  4/30/2019

  Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) announced its results for the first quarter ended March 31, 2019.

• Inmediata Health Group Notifies Patients of Data Security Incident

  4/26/2019

  Inmediata Health Group, Corp. recently became aware of a data security incident that may have involved the limited personal and medical information of some of its customers' patients.

• Triple-S Management Corporation Schedules First Quarter 2019 Earnings Release and Conference Call

  4/25/2019

  Triple-S Management Corporation (NYSE: GTS) today announced that it plans to release financial results for the first quarter ended March 31, 2019 before the market opens on Thursday, May 9, 2019.

• Auris Medical Provides Update on Tinnitus Drug Development Strategy

  4/25/2019

  Auris Medical Holding Ltd. provided an update on its tinnitus drug development strategy.

• Dr. Pedro Delgado Joins American University of the Caribbean School of Medicine Leadership Team

  4/24/2019

  Nationally recognized medical expert to join Sint Maarten community and lead medical sciences faculty